Daily Archives: September 11, 2022

Molecular markers of response to anti-PD1 therapy in advanced hepatocellular carcinoma

Posted on September 11, 2022 by Gastroenterology Journal

Single agent anti-PD1 checkpoint inhibitors convey outstanding clinical benefits in a small fraction (∼20%) of patients with advanced hepatocellular carcinoma (aHCC) but the molecular mechanisms determining response are unknown. To fill this gap, we he… Continue reading →

Posted in News | Comments Off on Molecular markers of response to anti-PD1 therapy in advanced hepatocellular carcinoma